February 9 2016, 17.07 PM IST || Pocket News Alert
Q3FY16 Consolidated operating income at Rs 3,981 mn (y-o-y of 16.7%) with EBITDA of Rs 437 mn (y-o-y of 113.6%)
9 Months FY16 Consolidated operating income at Rs 11,815 mn (y-o-y of 18.1%) with EBITDA of Rs 1,361 mn (y-o-y of 52.9%)
Bangalore, India, February 9,2016 – Narayana Hrudayalaya Limited (BSE:539551, NSE: NHL), a leading healthcare service provider in India, today announced its financial results for the third quarter (Q3FY16) and nine months’ period (9 Months FY16) ended December 31st,2015.
Key Highlights for the Quarter (Q3FY16)
§ Consolidated total operating income was Rs 3,981 mn for Q3FY16 as compared to Rs 3,413 mn in the corresponding period of the previous year reflecting an increase of 16.7%
§ Consolidated EBITDA stood at Rs 437 mn as compared to Rs 205 mn during the corresponding period of previous year reflecting an increase of 113.6%
§ Consolidated EBITDA Margin was at 11.0 % for Q3FY16 as against 6.0 % in Q3FY15
§ PAT after minority interest and share in associate stood at Rs 37 mn for Q3FY16 as compared to negative Rs (141) mn in the corresponding period of the previous year
Key Highlights for YTD Dec 2015 (9 Months FY 16)
§ Consolidated total operating income was Rs 11,815 mn for 9 Months FY16 as compared to Rs 10,005 mn in the corresponding period for last year reflecting an increase of 18.1%
§ Consolidated EBITDA stood at Rs 1,361 mn as compared to Rs 890 mn during the same period in the previous year reflecting an increase of 52.9%
§ Consolidated EBITDA Margin was at 11.5% for 9 Months FY16 as against 8.9% in 9 Months FY15
§ PAT after minority interest and share in associate stood at Rs 159 mn for 9 Months FY16 as compared to negative Rs (168) mn in the corresponding period for last year
As on 31st December, 2015, the consolidated net debt was Rs 1,740 mn representing a net debt to equity ratio of 0.19.
Other Highlights during the Quarter
§ One of our flagship hospitals, Mazumdar Shaw Medical Centre at Bangalore achieved the milestone of 500 Bone-Marrow Transplant procedures since its inception
§ Our hospital at Guwahati, Assam got NABH accreditation within 2 years of commencement of operations
Management Comment
Commenting on the performance, Dr. Ashutosh Raghuvanshi, Vice Chairman, Managing Director and Group CEO, Narayana Hrudayalaya Limited, said “Narayana Hrudayalaya’s Q3FY16 performance reflects the continued growth momentum and focus on financial and operational efficiencies inching up towards better profitability and sustained expansion. Our strategy of growth driven by calibrated capacity expansion & multiple layers of profitability drivers is aligned to the best interests of all the stakeholders. We thank you all for reposing faith upon us during the process of our company’s listing in the stock exchanges.”
